Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of PARP inhibitors: an unfinished story.

Oncology (Williston Park, N.Y.) - 1 Jan 2010

Patel Anand, Kaufmann Scott H

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mutation
Share to Antineoplastic Agents
Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Enzyme Inhibitors

Share to Poly(ADP-ribose) Polymerase Inhibitors

Source

Identifiers

PMID: 20187324

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of PARP inhibitors: an unfinished story.PMID 20187324Read ↗

PARP inhibitors: the story is still unfolding.Semantic proximity Read ↗

PARP inhibitors: pitfalls and promises.Semantic proximity Read ↗

PARP inhibitors coming of ageSemantic proximity Read ↗

EMBRACing a new PARP inhibitor?Semantic proximity Read ↗

Delving into PARP inhibition from bench to bedside and backSemantic proximity Read ↗

An update on PARP inhibitors—moving to the adjuvant settingSemantic proximity Read ↗

PARP Inhibition in Cancer: An Update on Clinical DevelopmentSemantic proximity Read ↗

PARP Inhibitors in Gynecologic Cancers: What Is the Next Big Development?Semantic proximity Read ↗

PARP inhibitors: New partners in the therapy of cancer and inflammatory diseasesSemantic proximity Read ↗

Understanding and overcoming resistance to PARP inhibitors in cancer therapySemantic proximity Read ↗

PARP inhibitors in cancer therapy: Two modes of attack on the cancer cell widening the clinical applicationsSemantic proximity Read ↗

Double-barreled gun: Combination of PARP inhibitor with conventional chemotherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.